DCT

1:23-cv-00331

Keryx Biopharma Inc v. Zydus Worldwide DMCC

General
Filed
03/24/23
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
51%